In T2D, patients with this metabolic disease tend to be older and have other comorbidities such as obesity or hypertension and overexpression of ACE2, inflammation, and endothelial activation related to insulin resistance [50, 51, 52]. This evidence concerns the gene ACE2 and metabolic disease.